Peggy Farnham

61.6k total citations · 4 hit papers
184 papers, 21.1k citations indexed

About

Peggy Farnham is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Peggy Farnham has authored 184 papers receiving a total of 21.1k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Molecular Biology, 40 papers in Genetics and 37 papers in Oncology. Recurrent topics in Peggy Farnham's work include Genomics and Chromatin Dynamics (100 papers), Epigenetics and DNA Methylation (66 papers) and RNA modifications and cancer (46 papers). Peggy Farnham is often cited by papers focused on Genomics and Chromatin Dynamics (100 papers), Epigenetics and DNA Methylation (66 papers) and RNA modifications and cancer (46 papers). Peggy Farnham collaborates with scholars based in United States, Canada and Switzerland. Peggy Farnham's co-authors include Sharon L. Squazzo, Amy S. Weinmann, Jill E. Slansky, John L. Rinn, Howard Y. Chang, Stephanie M. Bartley, L. Henry Goodnough, Michael A. Kertesz, Xiao Xu and Eran Segal and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Peggy Farnham

183 papers receiving 20.8k citations

Hit Papers

4 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs

2007 3.4k citations Sharon L. Squazzo, Peggy Farnham et al. profile →
The NIH Roadmap Epigenomics Mapping Consortium

2010 1.2k citations Peggy Farnham et al. profile →
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties

1992 777 citations Peggy Farnham et al. profile →
T-bet Regulates the Terminal Maturation and Homeostasis of NK and Vα14i NKT Cells

2004 592 citations Amy S. Weinmann, Peggy Farnham et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peggy Farnham United States	77	17.5k	4.7k	3.7k	3.6k	1.8k	184	21.1k
Ronald Conaway United States	77	17.6k 1.0×	3.3k 0.7×	2.7k 0.7×	3.5k 1.0×	1.5k 0.9×	189	20.6k
Joan Conaway United States	76	17.1k 1.0×	3.3k 0.7×	2.5k 0.7×	3.5k 1.0×	1.5k 0.8×	189	20.0k
Maarten van Lohuizen Netherlands	73	17.4k 1.0×	2.4k 0.5×	2.6k 0.7×	4.0k 1.1×	1.4k 0.8×	143	20.4k
Andrew J. Bannister United Kingdom	52	20.1k 1.1×	2.3k 0.5×	2.8k 0.8×	2.6k 0.7×	1.8k 1.0×	84	23.5k
Reuven Agami Netherlands	57	16.6k 0.9×	7.5k 1.6×	1.9k 0.5×	2.7k 0.7×	1.3k 0.7×	127	19.9k
Ari Melnick United States	84	16.7k 1.0×	4.1k 0.9×	2.0k 0.6×	3.8k 1.1×	3.9k 2.1×	355	23.9k
David W. Rose United States	58	14.8k 0.8×	2.2k 0.5×	5.6k 1.5×	3.1k 0.9×	2.2k 1.2×	91	19.5k
Kay Huebner United States	73	13.9k 0.8×	3.2k 0.7×	6.5k 1.8×	3.7k 1.0×	2.0k 1.1×	292	18.9k
Yoshihiro Nakatani United States	61	15.8k 0.9×	1.4k 0.3×	3.0k 0.8×	2.7k 0.8×	1.8k 1.0×	139	18.9k
Jérôme Eeckhoute France	37	14.2k 0.8×	2.4k 0.5×	3.6k 1.0×	1.9k 0.5×	1.7k 1.0×	68	18.2k

Countries citing papers authored by Peggy Farnham

Since Specialization

Citations

This map shows the geographic impact of Peggy Farnham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peggy Farnham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peggy Farnham more than expected).

Fields of papers citing papers by Peggy Farnham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peggy Farnham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peggy Farnham. The network helps show where Peggy Farnham may publish in the future.

Co-authorship network of co-authors of Peggy Farnham

This figure shows the co-authorship network connecting the top 25 collaborators of Peggy Farnham. A scholar is included among the top collaborators of Peggy Farnham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peggy Farnham. Peggy Farnham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Yi‐Tsung, Tong Xu, Zhifei Luo, et al.. (2022). FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer. Cancers. 14(7). 1717–1717. 11 indexed citations

O’Geen, Henriette, Julian Halmai, Kyle D. Fink, et al.. (2019). Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner. Epigenetics & Chromatin. 12(1). 26–26. 110 indexed citations

O’Geen, Henriette, Chonghua Ren, Charles M. Nicolet, et al.. (2017). dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression. Nucleic Acids Research. 45(17). 9901–9916. 161 indexed citations

Lay, Fides D., Yaping Liu, Theresa K. Kelly, et al.. (2015). The role of DNA methylation in directing the functional organization of the cancer epigenome. Genome Research. 25(4). 467–477. 75 indexed citations

Blattler, Adam & Peggy Farnham. (2013). Cross-talk between Site-specific Transcription Factors and DNA Methylation States. Journal of Biological Chemistry. 288(48). 34287–34294. 156 indexed citations

Jung, Christine, Sushma Iyengar, Kimberly R. Blahnik, et al.. (2012). Human ESC Self-renewal Promoting microRNAs Induce Epithelial–Mesenchymal Transition in Hepatocytes by Controlling the PTEN and TGFβ Tumor Suppressor Signaling Pathways. Molecular Cancer Research. 10(7). 979–991. 18 indexed citations

Farnham, Peggy. (2012). Thematic Minireview Series on Results from the ENCODE Project: Integrative Global Analyses of Regulatory Regions in the Human Genome. Journal of Biological Chemistry. 287(37). 30885–30887. 12 indexed citations

Blahnik, Kimberly R., Lei Dou, Henriette O’Geen, et al.. (2009). Sole-Search: an integrated analysis program for peak detection and functional annotation using ChIP-seq data. Nucleic Acids Research. 38(3). e13–e13. 95 indexed citations

Bieda, Mark, et al.. (2008). Analysis of the Mechanisms Mediating Tumor-Specific Changes in Gene Expression in Human Liver Tumors. Cancer Research. 68(8). 2641–2651. 36 indexed citations

10.

Cotterman, Rebecca, et al.. (2008). N-Myc Regulates a Widespread Euchromatic Program in the Human Genome Partially Independent of Its Role as a Classical Transcription Factor. Cancer Research. 68(23). 9654–9662. 106 indexed citations

11.

Komashko, Vitalina, Sharon L. Squazzo, Sushma Iyengar, et al.. (2008). Using ChIP-chip technology to reveal common principles of transcriptional repression in normal and cancer cells. Genome Research. 18(4). 521–532. 39 indexed citations

12.

Oberley, Matthew J., et al.. (2003). High-Throughput Screening of Chromatin Immunoprecipitates Using CpG-Island Microarrays. Methods in enzymology on CD-ROM/Methods in enzymology. 376. 315–334. 82 indexed citations

13.

Weinmann, Amy S., Stephanie M. Bartley, Theresa Zhang, Michael Q. Zhang, & Peggy Farnham. (2001). Use of Chromatin Immunoprecipitation To Clone Novel E2F Target Promoters. Molecular and Cellular Biology. 21(20). 6820–6832. 331 indexed citations

14.

Farnham, Peggy, et al.. (1999). Coexamination of Site-Specific Transcription Factor Binding and Promoter Activity in Living Cells. Molecular and Cellular Biology. 19(12). 8393–8399. 150 indexed citations

15.

Fry, Christopher J., Jill E. Slansky, & Peggy Farnham. (1997). Position-Dependent Transcriptional Regulation of the Murine Dihydrofolate Reductase Promoter by the E2F Transactivation Domain. Molecular and Cellular Biology. 17(4). 1966–1976. 55 indexed citations

16.

Farnham, Peggy, et al.. (1997). Myc versus USF: Discrimination at the cad Gene Is Determined by Core Promoter Elements. Molecular and Cellular Biology. 17(5). 2529–2537. 149 indexed citations

17.

Farnham, Peggy. (1996). Transcriptional control of cell growth : the E2F gene family. Springer eBooks. 20 indexed citations

18.

Farnham, Peggy. (1996). Transcriptional Control of Cell Growth. Current topics in microbiology and immunology. 8 indexed citations

19.

Farnham, Peggy, et al.. (1991). Cell cycle analysis of Krox-20, c-fos, and JE expression in proliferating NIH3T3 fibroblasts.. PubMed. 2(9). 465–73. 5 indexed citations

20.

Means, Anna L. & Peggy Farnham. (1990). Transcription Initiation from the Dihydrofolate Reductase Promoter Is Positioned by HIP1 Binding at the Initiation Site. Molecular and Cellular Biology. 10(2). 653–661. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact